Bio & Pharmaceuticals

NJ: Porton Opens U.S. Technology Center in Cranbury for Pharmaceuticals

6 Oct, 2016

Porton announced the establishment of Porton U.S.A, LLC, a new subsidiary and Process Innovation Center located in Cranbury, New Jersey (NJ), United States. Deploying state-of-the-art laboratories and some of the industry’s most capable and experienced scientists, Porton’s New Jersey, Center will provide customers with impactful solutions to complex process challenges, next-generation process development, gram to kilogram cGMP syntheses of specialized pharmaceutical intermediates and APIs including highly potent APIs and antibody drug conjugates, etc.  Through flexibly structured, yet close-knit collaborations and geographical proximity, Porton’s New Jersey, Center will bring new efficiencies to pharmaceutical development and lifecycle management for valued global customers.




Subscribe to our Newsletters

The only vertical market site selection publication that delivers industry insight and growth strategies right to your inbox. Incentives, real estate, workforce development – site selection news and information centered around markets that matter to you.